Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,43 USD | -5,70% |
|
-.--% | -5,70% |
Omzet 2024 * | 36,59 mld. 226 mln. 210 mln. | Omzet 2025 * | 39,05 mld. 242 mln. 224 mln. | Marktkapitalisatie | 148 mld. 913 mln. 846 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -852 mln. -5,27 mln. -4,89 mln. | Nettowinst (verlies) 2025 * | 2,54 mld. 15,7 mln. 14,56 mln. | EV/omzet 2024 * | 4,51 x |
Nettoschuld 2024 * | 17,38 mld. 108 mln. 99,69 mln. | Nettoliquiditeiten 2025 * | 14,05 mld. 86,94 mln. 80,6 mln. | EV/omzet 2025 * | 3,42 x |
K/w-verhouding 2024 * |
63,3
x | K/w-verhouding 2025 * |
27,8
x | Werknemers | 350 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,88% |
Recentste transcriptie over Nxera Pharma Co., Ltd.
1 dag | -5,70% | ||
1 maand | +6,31% | ||
3 maanden | -12,69% | ||
6 maanden | -5,70% | ||
Lopend jaar | -5,70% |
![Extreem 9.36](/images/extremecours_fleche.png)
![Extreem 8.56](/images/extremecours_fleche.png)
![Extreem 8.56](/images/extremecours_fleche.png)
![Extreem 8.44](/images/extremecours_fleche.png)
![Extreem 8.44](/images/extremecours_fleche.png)
![Extreem 8.03](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chris Cargill
CEO | Chief Executive Officer | 40 | 20-09-17 |
Shinichi Tamura
FOU | Founder | 74 | 22-06-90 |
Director of Finance/CFO | - | 24-03-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shinichi Tamura
FOU | Founder | 74 | 22-06-90 |
Noriaki Nagai
BRD | Director/Board Member | 66 | 27-03-19 |
Rolf Soderstrom
BRD | Director/Board Member | 59 | 25-03-20 |
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,88% | 93,97 mld. | |
+6,58% | 41,61 mld. | |
-13,20% | 33,32 mld. | |
+77,12% | 28,8 mld. | |
-16,02% | 15,61 mld. | |
-8,17% | 13,27 mld. | |
-12,49% | 11,46 mld. | |
+162,44% | 10,06 mld. | |
-54,92% | 9,09 mld. |
- Beurs
- Aandelen
- Koers 4565
- Koers SOLTF